Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
NTES Stock Summary
Top 10 Correlated ETFs
NTES
In the News
NTES Financial details
Company Rating
Strong Buy
Market Cap
57.81B
Income
26.79B
Revenue
101.68B
Book val./share
186.66
Cash/share
172.42
Dividend
1.76
Dividend %
1.96%
Employees
31.12K
Optionable
No
Shortable
Yes
Earnings
23 May 2024
P/E
15.38
Forward P/E
-
PEG
2.4
P/S
3.94
P/B
3.43
P/C
0.52
P/FCF
14.13
Quick Ratio
2.67
Current Ratio
2.91
Debt / Equity
0.1
LT Debt / Equity
0
-
-
EPS (TTM)
41.6
EPS next Y
-
EPS next Q
-
EPS this Y
20.59%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
26.31%
Revenue last 5Y
7.52%
Revenue Q/Q
13.57%
EPS Q/Q
-4.69%
-
-
-
-
SMA20
-12.15%
SMA50
-6.93%
SMA100
-18.97%
Inst Own
10.07%
Inst Trans
0.84%
ROA
16%
ROE
24%
ROC
0.2%
Gross Margin
58%
Oper. Margin
25%
Profit Margin
26%
Payout
29%
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
80.79-118.9
52W High
-23.62%
52W Low
+12.66%
RSI
29
Rel Volume
0.54
Avg Volume
1.68M
Volume
911.22K
Perf Week
-10.43%
Perf Month
-12.99%
Perf Quarter
-14.09%
Perf Half Y
-15.08%
-
-
-
-
Beta
0.557
-
-
Volatility
3.43%, 6.04%
Prev Close
-0.32%
Price
90.13
Change
-1.5%
NTES Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 103.79 | 91.98 | 111.43 | 131.7 | 147.84 | |
Net income per share | 9.51 | 20.91 | 18.25 | 25.34 | 31.16 | |
Operating cash flow per share | 20.73 | 26.73 | 37.65 | 37.47 | 42.45 | |
Free cash flow per share | 10.09 | 21.56 | 32.67 | 32.8 | 38.4 | |
Cash per share | 77.22 | 111.86 | 141.39 | 146.63 | 179.96 | |
Book value per share | 69.9 | 95.41 | 124.23 | 143.31 | 160.46 | |
Tangible book value per share | 65.72 | 91.42 | 118.74 | 142.18 | 157.17 | |
Share holders equity per share | 69.9 | 95.41 | 124.23 | 143.31 | 160.46 | |
Interest debt per share | 22.02 | 26.56 | 30.22 | 31.01 | 45.47 | |
Market cap | 209.41B | 274.9B | 413.18B | 431.4B | 326.94B | |
Enterprise value | 217.68B | 288.48B | 423.57B | 437.53B | 329.58B | |
P/E ratio | 34.04 | 20.41 | 34.25 | 25.59 | 16.08 | |
Price to sales ratio | 3.12 | 4.64 | 5.61 | 4.92 | 3.39 | |
POCF ratio | 15.61 | 15.97 | 16.6 | 17.31 | 11.8 | |
PFCF ratio | 32.07 | 19.79 | 19.13 | 19.77 | 13.04 | |
P/B Ratio | 4.63 | 4.47 | 5.03 | 4.53 | 3.12 | |
PTB ratio | 4.63 | 4.47 | 5.03 | 4.53 | 3.12 | |
EV to sales | 3.24 | 4.87 | 5.75 | 4.99 | 3.42 | |
Enterprise value over EBITDA | 21.53 | 19.14 | 21.72 | 25.39 | 15.8 | |
EV to operating cash flow | 16.23 | 16.76 | 17.02 | 17.55 | 11.89 | |
EV to free cash flow | 33.34 | 20.77 | 19.61 | 20.05 | 13.15 | |
Earnings yield | 0.03 | 0.05 | 0.03 | 0.04 | 0.06 | |
Free cash flow yield | 0.03 | 0.05 | 0.05 | 0.05 | 0.08 | |
Debt to equity | 0.3 | 0.28 | 0.24 | 0.22 | 0.26 | |
Debt to assets | 0.16 | 0.15 | 0.14 | 0.13 | 0.16 | |
Net debt to EBITDA | 0.82 | 0.9 | 0.53 | 0.36 | 0.13 | |
Current ratio | 1.96 | 2.23 | 2.31 | 2.24 | 2.32 | |
Interest coverage | 13.43 | 0 | 0 | 0 | 9.13 | |
Income quality | 2.07 | 1.28 | 2.02 | 1.47 | 1.44 | |
Dividend Yield | 0.01 | 0.03 | 0.01 | 0.01 | 0.02 | |
Payout ratio | 0.23 | 0.66 | 0.35 | 0.21 | 0.33 | |
Sales general and administrative to revenue | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | |
Research and developement to revenue | 0.12 | 0.14 | 0.14 | 0.16 | 0.16 | |
Intangibles to total assets | 0.04 | 0.03 | 0.03 | 0.03 | 0.02 | |
Capex to operating cash flow | -0.51 | -0.19 | -0.13 | -0.12 | -0.1 | |
Capex to revenue | -0.1 | -0.06 | -0.04 | -0.04 | -0.03 | |
Capex to depreciation | -3.31 | -1.27 | -0.95 | -0.95 | -0.92 | |
Stock based compensation to revenue | 0.04 | 0.04 | 0.04 | 0.03 | 0.03 | |
Graham number | 122.29 | 211.87 | 225.84 | 285.86 | 335.41 | |
ROIC | 0.1 | 0.14 | 0.11 | 0.11 | 0.12 | |
Return on tangible assets | 0.07 | 0.12 | 0.09 | 0.11 | 0.12 | |
Graham Net | 22.79 | 40.32 | 57.99 | 71.83 | 88.59 | |
Working capital | 33.61B | 46.86B | 61.09B | 62.62B | 74.77B | |
Tangible asset value | 42.52B | 58.89B | 78.82B | 95.17B | 104.75B | |
Net current asset value | 27.77B | 35.57B | 48.95B | 58.75B | 67.72B | |
Invested capital | 0.3 | 0.28 | 0.24 | 0.22 | 0.26 | |
Average receivables | 3.95B | 4.23B | 4.37B | 5.04B | 5.26B | |
Average payables | 2.41B | 1.8B | 1.17B | 1.06B | 1.25B | |
Average inventory | 5.25B | 2.83B | 635.88M | 792.97M | 979.18M | |
Days sales outstanding | 23.31 | 25.69 | 22.68 | 22.95 | 18.92 | |
Days payables outstanding | 22.46 | 15.98 | 11.94 | 8.85 | 12.58 | |
Days of inventory on hand | 47.26 | 8.58 | 6.54 | 8.67 | 8.29 | |
Receivables turnover | 15.66 | 14.21 | 16.1 | 15.91 | 19.29 | |
Payables turnover | 16.25 | 22.84 | 30.57 | 41.25 | 29.01 | |
Inventory turnover | 7.72 | 42.56 | 55.83 | 42.12 | 44.01 | |
ROE | 0.14 | 0.22 | 0.15 | 0.18 | 0.19 | |
Capex per share | -10.64 | -5.17 | -4.98 | -4.68 | -4.05 |
Quarterly Fundamentals Overview
Last date of statement is 2023-09-30 for Q3
Metric | History | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 37.43 | 39.14 | 38.88 | 37.3 | 42.43 | |
Net income per share | 10.27 | 6.1 | 10.49 | 12.8 | 12.19 | |
Operating cash flow per share | 11.47 | 13.91 | 9.31 | 11.93 | 15.31 | |
Free cash flow per share | 10.38 | 13.12 | 7.02 | 10.68 | 13.16 | |
Cash per share | 178.11 | 181.3 | 186.96 | 170.57 | 172.42 | |
Book value per share | 161.45 | 161.66 | 168.64 | 177.5 | 186.66 | |
Tangible book value per share | 161.46 | 158.35 | 168.29 | 177.27 | 186.44 | |
Share holders equity per share | 161.45 | 161.66 | 168.64 | 177.5 | 186.66 | |
Interest debt per share | 45.28 | 43.47 | 46.37 | 24.6 | 18.12 | |
Market cap | 351.47B | 324.52B | 391.44B | 451.39B | 470.03B | |
Enterprise value | 362.46B | 327.16B | 408.86B | 454.46B | 466.57B | |
P/E ratio | 13.12 | 20.52 | 14.49 | 13.69 | 14.99 | |
Price to sales ratio | 14.39 | 12.8 | 15.63 | 18.8 | 17.24 | |
POCF ratio | 46.95 | 36.02 | 65.23 | 58.79 | 47.75 | |
PFCF ratio | 51.86 | 38.19 | 86.58 | 65.66 | 55.57 | |
P/B Ratio | 3.34 | 3.1 | 3.6 | 3.95 | 3.92 | |
PTB ratio | 3.34 | 3.1 | 3.6 | 3.95 | 3.92 | |
EV to sales | 14.84 | 12.9 | 16.32 | 18.93 | 17.11 | |
Enterprise value over EBITDA | 133.74 | 56.08 | 49.75 | 91.41 | 57.93 | |
EV to operating cash flow | 48.42 | 36.31 | 68.14 | 59.19 | 47.4 | |
EV to free cash flow | 53.48 | 38.5 | 90.43 | 66.11 | 55.16 | |
Earnings yield | 0.02 | 0.01 | 0.02 | 0.02 | 0.02 | |
Free cash flow yield | 0.02 | 0.03 | 0.01 | 0.02 | 0.02 | |
Debt to equity | 0.28 | 0.26 | 0.29 | 0.14 | 0.1 | |
Debt to assets | 0.17 | 0.16 | 0.17 | 0.09 | 0.07 | |
Net debt to EBITDA | 4.06 | 0.45 | 2.12 | 0.62 | -0.43 | |
Current ratio | 2.31 | 2.32 | 2.33 | 2.93 | 2.91 | |
Interest coverage | 3.59 | 7.05 | -5.79 | 0 | 0 | |
Income quality | 1.13 | 2.36 | 0.89 | 0.94 | 1.26 | |
Dividend Yield | 0 | 0.01 | 0 | 0 | 0.01 | |
Payout ratio | 0.24 | 0.51 | 0.18 | 0.26 | 0.31 | |
Sales general and administrative to revenue | 0.05 | 0.05 | 0.04 | 0.05 | 0.05 | |
Research and developement to revenue | 0.16 | 0.16 | 0.15 | 0.16 | 0.16 | |
Intangibles to total assets | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | |
Capex to operating cash flow | -0.09 | -0.06 | -0.25 | -0.1 | -0.14 | |
Capex to revenue | -0.03 | -0.02 | -0.06 | -0.03 | -0.05 | |
Capex to depreciation | -0.99 | -0.66 | -1.37 | -1.22 | -2.13 | |
Stock based compensation to revenue | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | |
Graham number | 193.11 | 148.97 | 199.46 | 226.13 | 226.29 | |
ROIC | 0.01 | 0.03 | 0.04 | 0.04 | 0.05 | |
Return on tangible assets | 0.04 | 0.02 | 0.04 | 0.05 | 0.05 | |
Graham Net | 87.97 | 89.25 | 92.74 | 100.32 | 106.46 | |
Working capital | 74.56B | 74.77B | 77.37B | 81.88B | 83.7B | |
Tangible asset value | 105.37B | 104.75B | 108.41B | 114.12B | 119.84B | |
Net current asset value | 68.39B | 67.72B | 69.84B | 74.58B | 79.94B | |
Invested capital | 0.28 | 0.26 | 0.29 | 0.14 | 0.1 | |
Average receivables | 5.21B | 5.11B | 5.55B | 5.72B | 5.92B | |
Average payables | 904.68M | 1.19B | 1.17B | 785.86M | 801.97M | |
Average inventory | 888.34M | 963.27M | 934.97M | 841.63M | 764.46M | |
Days sales outstanding | 19.19 | 17.76 | 21.89 | 20.03 | 21.43 | |
Days payables outstanding | 7.31 | 11.2 | 7.37 | 6.92 | 7.54 | |
Days of inventory on hand | 7.86 | 7.38 | 7.77 | 7.54 | 6.31 | |
Receivables turnover | 4.69 | 5.07 | 4.11 | 4.49 | 4.2 | |
Payables turnover | 12.32 | 8.03 | 12.21 | 13.01 | 11.94 | |
Inventory turnover | 11.45 | 12.19 | 11.58 | 11.94 | 14.27 | |
ROE | 0.06 | 0.04 | 0.06 | 0.07 | 0.07 | |
Capex per share | -1.09 | -0.79 | -2.3 | -1.25 | -2.16 |
NTES Frequently Asked Questions
What is NetEase, Inc. stock symbol ?
NetEase, Inc. is a CN stock and trading under the symbol NTES
What is NetEase, Inc. stock quote today ?
NetEase, Inc. stock price is $90.13 today.
Is NetEase, Inc. stock public?
Yes, NetEase, Inc. is a publicly traded company.